[HTML][HTML] Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and-B bronchiolitis before and after pandemic restrictions in Rome
A Pierangeli, R Nenna, M Fracella, C Scagnolari… - Journal of Infection, 2023 - Elsevier
Objectives To scrutinize whether the high circulation of respiratory syncytial virus (RSV)
observed in 2021–2022 and 2022–2023 was due to viral diversity, we characterized RSV-A …
observed in 2021–2022 and 2022–2023 was due to viral diversity, we characterized RSV-A …
Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic …
W Cai, S Köndgen, K Tolksdorf, R Dürrwald… - …, 2024 - eurosurveillance.org
Background Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic
affected respiratory syncytial virus (RSV) circulation worldwide. Aim To describe, for children …
affected respiratory syncytial virus (RSV) circulation worldwide. Aim To describe, for children …
[HTML][HTML] Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus below the Subgroup Level
A globally implemented unified phylogenetic classification for human respiratory syncytial
virus (HRSV) below the subgroup level remains elusive. We formulated global consensus of …
virus (HRSV) below the subgroup level remains elusive. We formulated global consensus of …
Molecular epidemiology and genetic diversity of human respiratory syncytial virus in Sicily during pre-and post-COVID-19 surveillance seasons
Human respiratory syncytial virus (hRSV) is an important pathogen of acute respiratory tract
infection of global significance. In this study, we investigated the molecular epidemiology …
infection of global significance. In this study, we investigated the molecular epidemiology …
Molecular characterization of human respiratory syncytial virus in Seoul, South Korea, during 10 consecutive years, 2010–2019
HN Kim, J Hwang, SY Yoon, CS Lim, Y Cho, CK Lee… - PLoS …, 2023 - journals.plos.org
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections
and hospitalization in infants and young children. Here, we analyzed the genetic diversity of …
and hospitalization in infants and young children. Here, we analyzed the genetic diversity of …
Genomic characterization of respiratory syncytial virus genotypes circulating in the paediatric population of Sydney, NSW, Australia
Respiratory syncytial virus (RSV), or human orthopneumovirus, is a major cause of acute
lower respiratory infection (ALRI), particularly in young children, causing significant …
lower respiratory infection (ALRI), particularly in young children, causing significant …
Respiratory syncytial virus European laboratory network 2022 survey: need for harmonization and enhanced molecular surveillance
LD Presser, WMR van den Akker… - The Journal of Infectious …, 2024 - academic.oup.com
Respiratory syncytial virus (RSV) is a common pathogen causing mostly cold-like symptoms,
but in very young infants and elderly individuals it can lead to severe disease and even …
but in very young infants and elderly individuals it can lead to severe disease and even …
Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
A Lai, A Bergna, V Fabiano, C Ventura… - Frontiers in …, 2024 - frontiersin.org
Background Human respiratory syncytial virus (RSV) is the leading cause of acute lower
respiratory tract infection among infants and young children worldwide, with seasonal peaks …
respiratory tract infection among infants and young children worldwide, with seasonal peaks …
The unified proposal for classification of human respiratory syncytial virus below the subgroup level
A globally implemented unified classification for human respiratory syncytial virus (HRSV)
below the subgroup level remains elusive. Here, we formulate the global consensus of …
below the subgroup level remains elusive. Here, we formulate the global consensus of …
Diversity and evolution of computationally predicted T cell epitopes against human respiratory syncytial virus
Human respiratory syncytial virus (RSV) is a major cause of lower respiratory infection.
Despite more than 60 years of research, there is no licensed vaccine. While B cell response …
Despite more than 60 years of research, there is no licensed vaccine. While B cell response …